[go: up one dir, main page]

CN115153019A - A kind of preparation method of food for preventing and treating osteoarthritis - Google Patents

A kind of preparation method of food for preventing and treating osteoarthritis Download PDF

Info

Publication number
CN115153019A
CN115153019A CN202210899605.3A CN202210899605A CN115153019A CN 115153019 A CN115153019 A CN 115153019A CN 202210899605 A CN202210899605 A CN 202210899605A CN 115153019 A CN115153019 A CN 115153019A
Authority
CN
China
Prior art keywords
food
preventing
preparing
stirring
speed stirring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210899605.3A
Other languages
Chinese (zh)
Inventor
李奕颉
辛冬梅
林银银
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong Hearun Dietary Hall Co ltd
Original Assignee
Shandong Hearun Dietary Hall Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong Hearun Dietary Hall Co ltd filed Critical Shandong Hearun Dietary Hall Co ltd
Priority to CN202210899605.3A priority Critical patent/CN115153019A/en
Publication of CN115153019A publication Critical patent/CN115153019A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

本发明公开了一种预防及治疗骨关节病食品的制备方法,它属于食品加工领域,包括以下步骤:(1)从魔芋中提取KGM粉;(2)将KGM30KG,GH4.5~7.5Kg、CS2.5‑6Kg投入25‑30℃的957~963Kg的纯净水中搅拌膨润放置得到糊状混合物;(3)糊状混合物中加入食品级氢氧化钙精炼并获得精炼制品;(4)精炼制品定型后自然熟成;(5)计量杀菌包装。通过上述制备的食品,可对骨关节病器到“药食兼用,药食同疗”的目的。The invention discloses a preparation method of food for preventing and treating osteoarthritis, which belongs to the field of food processing and comprises the following steps: (1) extracting KGM powder from konjac; (2) preparing KGM30KG, GH4.5-7.5Kg, CS2.5-6Kg is put into pure water of 957-963Kg at 25-30℃, stirred and swelled and placed to obtain a paste mixture; (3) Add food grade calcium hydroxide to the paste mixture to refine and obtain refined products; (4) Refined products Natural ripening after shaping; (5) Measured sterilization packaging. The food prepared above can achieve the purpose of "medicine and food, and co-treatment with food and medicine" for bone and joint disease organs.

Description

一种预防及治疗骨关节病食品的制备方法A kind of preparation method of food for preventing and treating osteoarthritis

技术领域technical field

本发明涉及食品加工领域,具体涉及一种预防及治疗骨关节病食品的制备方法。The invention relates to the field of food processing, in particular to a preparation method of food for preventing and treating osteoarthritis.

背景技术Background technique

骨关节病(osteoarthritis,OA)是一种在临床上比较常见的疾病,好发于负重较大的膝关节、脊柱、髋关节及远侧指间关节部位及远侧指间关节部位,由炎症、感染、退化、创伤或其他因素引起的炎性疾病,在中老年人群中发病率较高,其他人群如运动员、教师、白领阶层人员、久坐电脑前工作者、司机、过度健身和户外运动人员等特殊群体中发病率高于50%,在中国相关患者有1亿以上,美国疾病控制中心资料显示,约占美国总人口1/4的人患有骨关节病。因其具有较高的发病率和致残率而受到医学界的普遍关注。在国内,对于这种顽固性疾病只能依靠病发后吃药打针进行治疗,且现有的治疗制品类大多数以药物形式存在。Osteoarthritis (OA) is a clinically common disease that occurs in the knee joint, spine, hip joint, and distal interphalangeal joints and distal interphalangeal joints with heavy load. , Inflammatory diseases caused by infection, degeneration, trauma or other factors, the incidence is higher in middle-aged and elderly people, other groups such as athletes, teachers, white-collar workers, sedentary computer workers, drivers, excessive fitness and outdoor sports The incidence rate in special groups such as personnel is higher than 50%, and there are more than 100 million related patients in China. According to the US Centers for Disease Control, about 1/4 of the US population suffers from osteoarthritis. Because of its high morbidity and disability rate, it has received widespread attention from the medical community. In China, this intractable disease can only be treated by taking medicines and injections after the onset of the disease, and most of the existing therapeutic products exist in the form of drugs.

魔芋属天南星科多年生草本植物,在我国西南部地区和中西部地区有着悠久的种植历史。魔芋的主要成分是葡甘露聚糖(Konjac Glucomannan,KGM),是一种低热能、低蛋白质、高膳食纤维的食品,在碱性环境下会形成不可逆胶,延缓胃部排空的时间。又因魔芋含有铬,能延缓葡萄糖的吸收,使人体内摄入的葡萄糖代谢处于良性循环中,不会因葡萄糖类物质摄入使血糖骤然升高的情况出现。也适合肥胖人群、劳动强度大的人群、运动员等人群。Konjac is a perennial herb of Araceae and has a long history of planting in the southwestern and central and western regions of my country. The main component of konjac is glucomannan (Konjac Glucomannan, KGM), which is a low-calorie, low-protein, high dietary fiber food. It will form irreversible glue in an alkaline environment and delay gastric emptying time. And because konjac contains chromium, it can delay the absorption of glucose, so that the metabolism of glucose ingested in the human body is in a virtuous cycle, and the blood sugar will not rise suddenly due to the intake of glucose substances. It is also suitable for obese people, labor-intensive people, athletes and other groups.

硫酸软骨素(Chondroitin Sulfate,CS)是来自动物喉骨、鼻软骨、气管等富含软骨组织的一类重要酸性高分子多糖,具有多种重要生物活性。目前CS的主要应用领域是OA症状的治疗。CS治疗OA在发达国家已经很普及,在美国,CS是治疗OA应用最为广泛的膳食补充剂。Chondroitin Sulfate (CS) is an important acidic macromolecular polysaccharide derived from animal laryngeal, nasal cartilage, trachea and other cartilage-rich tissues. It has a variety of important biological activities. The main application area of CS today is the treatment of OA symptoms. CS treatment of OA has become popular in developed countries, and in the United States, CS is the most widely used dietary supplement for the treatment of OA.

氨基葡萄糖是一种氨基单糖,是合成糖蛋白和糖脂的必备物质并大量表达于关节软骨、椎间盘和关节液中。氨基葡萄糖可从甲壳类动物的壳聚糖和甲壳素外骨骼中提取,经过硫酸化或盐酸化后变成稳定的可以口服的硫酸氨基葡糖(glucosamine sulfate,GH)或盐酸氨基葡萄糖(glucosamine hydrochloride,GH)。氨基葡萄糖的作用最早被认为是参与透明质酸及聚氨基葡萄糖的合成,维持正常软骨结构。各种体外、体内试验研究结果显示,氨基葡萄糖除具有抗氧化、抗炎症的特点,还能抑制损伤关节软骨的基质金属蛋白酶和磷脂酶A2,防止受损软骨细胞内超氧化物自由基的产生,避免糖皮质激素对软骨细胞的损害,预防非甾体抗炎药对体内氨基葡萄糖生物合成的损害。Glucosamine, an amino monosaccharide, is an essential substance for the synthesis of glycoproteins and glycolipids and is abundantly expressed in articular cartilage, intervertebral disc and synovial fluid. Glucosamine can be extracted from the chitosan and chitin exoskeletons of crustaceans, and after sulfation or hydrochlorination, it becomes stable orally available glucosamine sulfate (GH) or glucosamine hydrochloride (glucosamine hydrochloride). , GH). The role of glucosamine was first thought to be involved in the synthesis of hyaluronic acid and polyglucosamine to maintain normal cartilage structure. The results of various in vitro and in vivo experiments show that glucosamine not only has the characteristics of anti-oxidation and anti-inflammatory, but also inhibits matrix metalloproteinase and phospholipase A2 that damage articular cartilage, and prevents the production of superoxide free radicals in damaged cartilage cells. , to avoid the damage of glucocorticoids to chondrocytes, and to prevent the damage of glucosamine biosynthesis in vivo by non-steroidal anti-inflammatory drugs.

近年来,随着药品和保健品行业的不断发展,中国市面上的主要是通过CS和GH的配合以药物、药丸、胶囊形式出现。在北美地区,特别是美国,CS和GH都是作为食品补充剂销售。虽然GH和CS的安全性较好,现有的临床随机试验尚无严重或致死性等不良反应的报道。但是GH是一种盐类复合物,含有氯化钠,常规服用GH后盐分的摄入量可达日常需要量的30%,可能增加老年人高血压,心脑血管事件风险,此外,有文献报道GH可影响糖代谢导致胰岛素抵抗。此外药片、药丸、胶囊中的载体成分淀粉、油脂类物质既不利于人体消化吸收,同时也降低了药物疗效导致口服摄入的CS部分在胃肠道中被吸收,其余随粪便排泄。生物利用率只有12%左右。根据静脉输注CS的药动力学研究,证实CS在循环系统中的半衰期为3~15min。In recent years, with the continuous development of the pharmaceutical and health care products industry, the products on the market in China mainly appear in the form of drugs, pills and capsules through the combination of CS and GH. In North America, especially the United States, both CS and GH are marketed as food supplements. Although the safety of GH and CS is good, there are no reports of serious or fatal adverse reactions in the existing randomized clinical trials. However, GH is a salt complex containing sodium chloride. After regular use of GH, the intake of salt can reach 30% of the daily requirement, which may increase the risk of hypertension and cardiovascular and cerebrovascular events in the elderly. In addition, there are literatures reported that GH can affect glucose metabolism leading to insulin resistance. In addition, the carrier components starch and oily substances in tablets, pills and capsules are not conducive to human digestion and absorption, but also reduce the efficacy of the drug, so that part of CS taken orally is absorbed in the gastrointestinal tract, and the rest is excreted with feces. Bioavailability is only about 12%. According to the pharmacokinetic study of intravenous infusion of CS, it is confirmed that the half-life of CS in the circulatory system is 3-15min.

鉴于以上问题,我公司研发了一种预防及治疗骨关节病食品的制备方法,以期望实现“药食兼用,药食同疗”的目的。In view of the above problems, our company has developed a preparation method of food for the prevention and treatment of osteoarthritis, in order to achieve the purpose of "combining medicine and food, and treating both medicine and food".

发明内容SUMMARY OF THE INVENTION

对于现有技术中所存在的问题,本发明提供的一种预防及治疗骨关节病食品的制备方法,能够实现“药食兼用,药食同疗”的目的。For the problems existing in the prior art, the present invention provides a preparation method of a food for preventing and treating osteoarthritis, which can achieve the purpose of "combining medicine and food, and co-treatment with medicine and food".

为了实现上述目的,本发明采用的技术方案如下:一种预防及治疗骨关节病食品的制备方法,包括以下步骤:In order to achieve the above object, the technical scheme adopted in the present invention is as follows: a preparation method of food for preventing and treating osteoarthritis, comprising the following steps:

(1)从魔芋中提取KGM粉;(1) Extract KGM powder from konjac;

(2)将KGM30KG,GH4.5~7.5Kg、CS2.5-6Kg投入25-30℃的957~963Kg的纯净水中搅拌膨润放置得到糊状混合物;(2) KGM30KG, GH4.5~7.5Kg, CS2.5-6Kg are put into the pure water of 957~963Kg of 25-30 ℃, stirring and swelling are placed to obtain a paste mixture;

(3)糊状混合物中加入食品级氢氧化钙精炼并获得精炼制品;(3) adding food-grade calcium hydroxide to the pasty mixture for refining and obtaining a refined product;

(4)精炼制品定型后自然熟成;(4) Natural maturation of refined products after finalization;

(5)计量杀菌包装。(5) Measured sterilization packaging.

优选的,第(2)步中,糊状混合物以KGM为载体,包裹CS和GH。Preferably, in step (2), the paste mixture uses KGM as a carrier to encapsulate CS and GH.

优选的,第(4)步中,采用70℃-80℃的热纯净水自然熟成12小时以上。Preferably, in step (4), use hot purified water at 70°C-80°C to naturally mature for more than 12 hours.

优选的,自然熟成的精炼制品PH值为11.5-12。Preferably, the pH value of the naturally aged refined product is 11.5-12.

优选的,所述精炼制品定型时需将精炼制品放置到模具中,利用65℃-70℃的水定型10分钟。Preferably, when the refined product is shaped, the refined product needs to be placed in a mold and shaped with water at 65°C-70°C for 10 minutes.

优选的,第(2)步中的搅拌过程为先低速搅拌后高速搅拌,搅拌结束后膨润放置至少90分钟。Preferably, the stirring process in step (2) is to stir at a low speed first and then stir at a high speed, and after the stirring is completed, it is left to swell for at least 90 minutes.

优选的,低速搅拌时长大于高速搅拌时长。Preferably, the duration of low-speed stirring is longer than that of high-speed stirring.

优选的,所述低速搅拌的搅拌时长为至少15分钟,所述高速搅拌的搅拌时长为至少5分钟。Preferably, the stirring duration of the low-speed stirring is at least 15 minutes, and the stirring duration of the high-speed stirring is at least 5 minutes.

优选的,第(3)步中食品级氢氧化钙的加入量为糊状混合物质量的10%。Preferably, the amount of food-grade calcium hydroxide added in step (3) is 10% of the mass of the paste mixture.

优选的,第(3)步中精炼过程需不断搅拌。Preferably, the refining process in step (3) requires constant stirring.

该发明的有益之处在于:The benefits of this invention are:

1、本发明制备的食品,可达到“药食兼用,药食同疗”的目的。1. The food prepared by the present invention can achieve the purpose of "combining medicine and food, and treating both medicine and food".

2、本发明制备的食品,以魔芋KGM为载体,包裹配合CS和GH制作为固态食品,不以淀粉、油脂作为载体,充分利用KGM为可溶性膳食纤维的特性,有利于人体的消化和吸收,提高了药物的疗效。2. The food prepared by the present invention is made of konjac KGM as a carrier, wrapped with CS and GH to make solid food, without starch and oil as a carrier, and makes full use of the characteristics of KGM as a soluble dietary fiber, which is beneficial to the digestion and absorption of the human body, Improve the efficacy of the drug.

3、本发明制备的食品,在起到预防治疗关节炎的同时,降低了GH作为盐类复合物带来的高血压,心脑血管疾病。充分发挥魔芋KGM的降血脂、降血压的属性。规避GH带来的三高风险。因CS作为酸性粘多糖的抗凝血作用已被广泛认可,CS作为一种酸性粘多糖,其化学结构与肝素相似,并不依赖于抗凝血酶Ⅲ,而是通过纤维蛋白原系统发挥抗凝血作用,在与KGM配合使用时可以起到协同增效的作用。3. The food prepared by the present invention can prevent and treat arthritis, and at the same time reduce hypertension and cardiovascular and cerebrovascular diseases caused by GH as a salt compound. Give full play to the properties of konjac KGM in lowering blood lipids and lowering blood pressure. Avoid the three high risks brought by GH. Because the anticoagulant effect of CS as an acid mucopolysaccharide has been widely recognized, CS, as an acid mucopolysaccharide, has a chemical structure similar to heparin, and does not depend on antithrombin III, but exerts anticoagulant through the fibrinogen system. The coagulation effect can be synergistic when used in combination with KGM.

4、目前对于OA患者来说只能是OA爆发后对症治疗,而对OA来说后期的治疗只能起到维持和缓解的效果,对于此类病情预防应重在日常,提早食用氨糖硫酸软骨素制品对骨关节进行维护能更好的预防骨关节疾病的发生,本发明制备的食品可作为一日三餐食用,以食品作为媒介,以KGM作为载体,口感顺滑、有弹性,在便于食用的同时达到强健骨骼和预防OA的目的,对于预防OA发挥着举足轻重的作用,此发明尚属国内首例。4. At present, for OA patients, it can only be symptomatic treatment after the outbreak of OA, while for OA, the later treatment can only have the effect of maintenance and remission. For the prevention of such diseases, the focus should be on daily life, and glucosamine sulfate should be consumed early. The maintenance of bone and joint by chondroitin products can better prevent the occurrence of bone and joint diseases, the food prepared by the invention can be eaten as three meals a day, with food as a medium and KGM as a carrier, the taste is smooth and elastic, and the food is smooth and elastic. It is easy to eat while achieving the purpose of strengthening bones and preventing OA. It plays a pivotal role in preventing OA. This invention is the first case in China.

5、本发明制备的食品为碱性食品PH11.5-12,避免了CS遇酸不稳定的情况,没有任何的副作用和不良反应。单独服用CS会产生胃肠道不适症状,这是目前国内唯一报道的CS不良反应,原因是其含有的硫酸根进入人体内引起的胃酸不适产生,本发明制备的食品为碱性食品采用葡甘露聚糖包裹CS和GH的方式,为碱性食品,可以缓解CS等产生的胃酸过多,造成的胃肠不适感,内含有的KGM可溶性膳食纤维可延缓胃部排空的时间,缓慢吸收,增加药效时间,延长CS和GH在生物体内吸收、分布的时间,使其CS系统分布于结缔组织,解决免疫系统介导作用,提高生物利用度。5. The food prepared by the present invention is alkaline food with pH 11.5-12, which avoids the instability of CS in the presence of acid, and does not have any side effects and adverse reactions. Taking CS alone will produce gastrointestinal discomfort symptoms, which is the only reported CS adverse reaction in China. The reason is that the sulfate radicals it contains enter the human body and cause gastric acid discomfort. The food prepared by the present invention is an alkaline food and adopts glucomannan. The way that glycans encapsulate CS and GH is an alkaline food, which can relieve the gastrointestinal discomfort caused by excessive gastric acid produced by CS, etc. The KGM soluble dietary fiber contained in it can delay the time of gastric emptying and absorb slowly. Increase the efficacy time, prolong the absorption and distribution time of CS and GH in the body, make the CS system distribute in the connective tissue, solve the mediation effect of the immune system, and improve the bioavailability.

6、本发明制备的食品特别适合于肥胖人群,劳动强度大、运动员、老年人等易发生OA的人群,因其含有的KGM成分低热量、高膳食纤维,低脂肪,在预防治疗OA的同时,又因其含有丰富的钙元素。可以起到缓解关节疼痛、抗炎镇痛、提高关节刚度效果显著。6. The food prepared by the present invention is particularly suitable for obese people, people with high labor intensity, athletes, the elderly and other people who are prone to OA, because the KGM components it contains are low in calories, high in dietary fiber, and low in fat, which can prevent and treat OA at the same time. , and because it is rich in calcium. It can play a significant role in relieving joint pain, anti-inflammatory and analgesic, and improving joint stiffness.

具体实施方式Detailed ways

为了便于本领域技术人员理解,下面对本发明作进一步的说明。In order to facilitate the understanding of those skilled in the art, the present invention is further described below.

一种预防及治疗骨关节病食品的制备方法,包括以下步骤:A preparation method of food for preventing and treating osteoarthritis, comprising the following steps:

(1)从魔芋中提取KGM粉;(1) Extract KGM powder from konjac;

(2)将KGM30KG,GH4.5~7.5Kg、CS2.5-6Kg投入25-30℃的957~963Kg的纯净水中搅拌膨润放置得到糊状混合物,该过程糊状混合物以KGM为载体,包裹CS和GH,其中的搅拌过程为先低速搅拌后高速搅拌,低速搅拌时长大于高速搅拌时长,搅拌结束后膨润放置至少90分钟,低速搅拌的搅拌时长为至少15分钟,所述高速搅拌的搅拌时长为至少5分钟;(2) Put KGM30KG, GH4.5~7.5Kg, CS2.5-6Kg into pure water of 957~963Kg at 25-30°C, stir, swell and place to obtain a paste mixture. In this process, the paste mixture takes KGM as a carrier and is wrapped CS and GH, wherein the stirring process is first low-speed stirring and then high-speed stirring, the low-speed stirring time is longer than the high-speed stirring time, and after stirring, the swelling is placed for at least 90 minutes, and the stirring time of the low-speed stirring is at least 15 minutes, and the stirring of the high-speed stirring The duration is at least 5 minutes;

(3)糊状混合物中加入食品级氢氧化钙精炼并获得精炼制品,食品级氢氧化钙的加入量为糊状混合物质量的10%,且精炼过程需不断搅拌;(3) adding food-grade calcium hydroxide to the pasty mixture for refining and obtaining a refined product, the amount of food-grade calcium hydroxide added is 10% of the mass of the pasty mixture, and the refining process needs to be continuously stirred;

(4)精炼制品定型后自然熟成,精炼制品具体定型时需将精炼制品放置到模具中,利用65℃-70℃的水定型10分钟,然后再采用70℃-80℃的热纯净水自然熟成12小时以上,自然熟成的精炼制品PH值为11.5-12;(4) The refined products are naturally matured after being shaped. When the refined products are specifically shaped, the refined products need to be placed in the mold, shaped with water at 65°C-70°C for 10 minutes, and then naturally matured with hot purified water at 70°C-80°C. For more than 12 hours, the PH value of naturally matured refined products is 11.5-12;

(5)计量杀菌包装。(5) Measured sterilization packaging.

以上述方法最后制备的食品,可达到“药食兼用,药食同疗”的目的。该食品以魔芋KGM为载体,包裹配合CS和GH制作为固态食品,不以淀粉、油脂作为载体,充分利用KGM为可溶性膳食纤维的特性,有利于人体的消化和吸收,提高了药物的疗效。The food finally prepared by the above method can achieve the purpose of "both medicine and food, and simultaneous treatment with medicine and food". The food is made of konjac KGM as a carrier, wrapped with CS and GH to make a solid food, without starch and oil as a carrier, making full use of the characteristics of KGM as a soluble dietary fiber, which is beneficial to the digestion and absorption of the human body, and improves the curative effect of the drug.

本发明制备的食品,在起到预防治疗关节炎的同时,降低了GH作为盐类复合物带来的高血压,心脑血管疾病。充分发挥魔芋KGM的降血脂、降血压的属性。规避GH带来的三高风险。因CS作为酸性粘多糖的抗凝血作用已被广泛认可,CS作为一种酸性粘多糖,其化学结构与肝素相似,并不依赖于抗凝血酶Ⅲ,而是通过纤维蛋白原系统发挥抗凝血作用,在与KGM配合使用时可以起到协同增效的作用。The food prepared by the invention can prevent and treat arthritis, and at the same time reduce hypertension and cardiovascular and cerebrovascular diseases caused by GH as a salt compound. Give full play to the properties of konjac KGM in lowering blood lipids and lowering blood pressure. Avoid the three high risks brought by GH. Because the anticoagulant effect of CS as an acid mucopolysaccharide has been widely recognized, CS, as an acid mucopolysaccharide, has a chemical structure similar to heparin, and does not depend on antithrombin III, but exerts anticoagulant through the fibrinogen system. The coagulation effect can be synergistic when used in combination with KGM.

目前对于OA患者来说只能是OA爆发后对症治疗,而对OA来说后期的治疗只能起到维持和缓解的效果,对于此类病情预防应重在日常,提早食用氨糖硫酸软骨素制品对骨关节进行维护能更好的预防骨关节疾病的发生,本发明制备的食品可作为一日三餐食用,以食品作为媒介,以KGM作为载体,口感顺滑、有弹性,在便于食用的同时达到强健骨骼和预防OA的目的,对于预防OA发挥着举足轻重的作用,此发明尚属国内首例。At present, OA patients can only be treated symptomatically after the outbreak of OA. For OA, the later treatment can only achieve maintenance and remission effects. The prevention of such diseases should focus on daily life, and early consumption of glucosamine and chondroitin sulfate The maintenance of the bone and joint by the product can better prevent the occurrence of bone and joint diseases. The food prepared by the present invention can be eaten as three meals a day, with the food as the medium and KGM as the carrier, the taste is smooth and elastic, and it is easy to eat. At the same time, it achieves the purpose of strengthening bones and preventing OA, and plays a pivotal role in preventing OA. This invention is the first case in China.

本发明制备的食品为碱性食品PH11.5-12,避免了CS遇酸不稳定的情况,没有任何的副作用和不良反应。单独服用CS会产生胃肠道不适症状,这是目前国内唯一报道的CS不良反应,原因是其含有的硫酸根进入人体内引起的胃酸不适产生,本发明制备的食品为碱性食品采用葡甘露聚糖包裹CS和GH的方式,为碱性食品,可以缓解CS等产生的胃酸过多,造成的胃肠不适感,内含有的KGM可溶性膳食纤维可延缓胃部排空的时间,缓慢吸收,增加药效时间,延长CS和GH在生物体内吸收、分布的时间,使其CS系统分布于结缔组织,解决免疫系统介导作用,提高生物利用度。The food prepared by the invention is an alkaline food with pH of 11.5-12, which avoids the instability of CS when encountering acid, and does not have any side effects and adverse reactions. Taking CS alone will produce gastrointestinal discomfort symptoms, which is the only reported CS adverse reaction in China. The reason is that the sulfate radicals it contains enter the human body and cause gastric acid discomfort. The food prepared by the present invention is an alkaline food and adopts glucomannan. The way that glycans encapsulate CS and GH is an alkaline food, which can relieve the gastrointestinal discomfort caused by excessive gastric acid produced by CS, etc. The KGM soluble dietary fiber contained in it can delay the time of gastric emptying and absorb slowly. Increase the efficacy time, prolong the absorption and distribution time of CS and GH in the body, make the CS system distribute in the connective tissue, solve the mediation effect of the immune system, and improve the bioavailability.

本发明制备的食品特别适合于肥胖人群,劳动强度大、运动员、老年人等易发生OA的人群,因其含有的KGM成分低热量、高膳食纤维,低脂肪,在预防治疗OA的同时,又因其含有丰富的钙元素。可以起到缓解关节疼痛、抗炎镇痛、提高关节刚度效果显著。The food prepared by the invention is particularly suitable for obese people, people with high labor intensity, athletes, the elderly and other people who are prone to OA, because the KGM components contained in the invention are low in calories, high in dietary fiber and low in fat, and can prevent and treat OA at the same time. Because it is rich in calcium. It can play a significant role in relieving joint pain, anti-inflammatory and analgesic, and improving joint stiffness.

应当理解,这些实施例的用途仅用于说明本发明而非意欲限制本发明的保护范围。此外,也应理解,在阅读了本发明的技术内容之后,本领域技术人员可以对本发明做各种改动、修改和/或变型,所有的这些等价形式同样落于本申请所附权利要求书所限定的保护范围之内。It should be understood that the purposes of these embodiments are only used to illustrate the present invention and are not intended to limit the protection scope of the present invention. In addition, it should also be understood that after reading the technical content of the present invention, those skilled in the art can make various changes, modifications and/or modifications to the present invention, and all these equivalent forms also fall within the appended claims of this application. within the limited scope of protection.

Claims (10)

1. The preparation method of the food for preventing and treating osteoarthropathy is characterized by comprising the following steps:
(1) Extracting KGM powder from konjak;
(2) KGM30KG, GH 4.5-7.5 Kg and CS2.5-6Kg are put into 957-963 Kg of purified water at 25-30 ℃ to be stirred, swelled and placed to obtain a pasty mixture;
(3) Adding food-grade calcium hydroxide into the pasty mixture for refining to obtain a refined product;
(4) Naturally ripening the refined product after shaping;
(5) And (6) metering, sterilizing and packaging.
2. The method for preparing a food for preventing and treating osteoarthropathy according to claim 1, wherein the paste mixture of step (2) is coated with CS and GH using KGM as a carrier.
3. The method for preparing a food for preventing and treating osteoarthropathy according to claim 1, wherein the natural aging is carried out for more than 12 hours in the step (4) using hot purified water of 70-80 ℃.
4. The method for preparing a food for the prevention and treatment of osteoarthropathy according to claim 1, wherein the naturally matured refined product has a pH of 11.5 to 12.
5. The method for preparing a food for preventing and treating osteoarthropathy according to claim 1, wherein the refined product is shaped by placing the refined product in a mold and shaping with water at 65-70 ℃ for 10 minutes.
6. The method for preparing a food for preventing and treating osteoarthropathy according to claim 1, wherein the stirring process in the step (2) is low speed stirring and high speed stirring, and the food is swollen and left for at least 90 minutes after the stirring is finished.
7. The method for preparing food for preventing and treating osteoarthropathy according to claim 6, wherein the low-speed stirring time is longer than the high-speed stirring time.
8. The method for preparing food for preventing and treating osteoarthropathy according to claim 7, wherein the stirring time of the low speed stirring is at least 15 minutes, and the stirring time of the high speed stirring is at least 5 minutes.
9. The method for preparing a food for the prevention and treatment of osteoarthropathy according to claim 1, wherein the food grade calcium hydroxide is added in an amount of 10% by mass of the paste mixture in the step (3).
10. The method for preparing a food for preventing and treating osteoarthropathy according to claim 1, wherein the refining process in the step (3) requires continuous stirring.
CN202210899605.3A 2022-07-28 2022-07-28 A kind of preparation method of food for preventing and treating osteoarthritis Pending CN115153019A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210899605.3A CN115153019A (en) 2022-07-28 2022-07-28 A kind of preparation method of food for preventing and treating osteoarthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210899605.3A CN115153019A (en) 2022-07-28 2022-07-28 A kind of preparation method of food for preventing and treating osteoarthritis

Publications (1)

Publication Number Publication Date
CN115153019A true CN115153019A (en) 2022-10-11

Family

ID=83478372

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210899605.3A Pending CN115153019A (en) 2022-07-28 2022-07-28 A kind of preparation method of food for preventing and treating osteoarthritis

Country Status (1)

Country Link
CN (1) CN115153019A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103554543A (en) * 2013-10-31 2014-02-05 昆明理工大学 Preparation method of konjac glucomannan fiber scaffold material
US20160192689A1 (en) * 2013-07-31 2016-07-07 Wikifoods, Inc. Encapsulated functional food compositions
CN114304640A (en) * 2021-12-16 2022-04-12 南京工业大学 A kind of polysaccharide composition for protecting gastric mucosa, preparation method and application thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160192689A1 (en) * 2013-07-31 2016-07-07 Wikifoods, Inc. Encapsulated functional food compositions
CN103554543A (en) * 2013-10-31 2014-02-05 昆明理工大学 Preparation method of konjac glucomannan fiber scaffold material
CN114304640A (en) * 2021-12-16 2022-04-12 南京工业大学 A kind of polysaccharide composition for protecting gastric mucosa, preparation method and application thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
杨勇等: "盐酸氨基葡萄糖联合硫酸软骨素治疗腰椎小关节骨关节炎的临床观察", 华西医学, vol. 27, no. 12, pages 1809 - 1813 *
詹益兴等: "绿色精细化工 天然产品制造法 第2集", vol. 1, 31 July 2006, 科学技术文献出版社, pages: 52 *
邓舜扬等: "功能性食品与保健", vol. 1, 31 August 2006, 科学技术文献出版社, pages: 203 *

Similar Documents

Publication Publication Date Title
CN101606704B (en) Dietary fiber food with multiple functional effects
JP2017537101A (en) Dietary fiber composition
CN103393713B (en) The application in the medicine of preparation treatment constipation of hyaluronic acid and salt thereof
CN106072651B (en) It is a kind of with increasing bone density, composition of anti-inflammatory and analgesic effect and preparation method thereof
CN103735572A (en) Composition having bone mineral density increasing function, anti-inflammatory function and analgesia function, and preparation method of the composition
CN111467481A (en) Composition for improving and/or preventing osteoarthritis and application thereof
CN116711862B (en) Composition for improving bone mineral density and application thereof
CN109924485A (en) A kind of slimming health food and preparation method thereof containing hyaluronic acid
CN107198246A (en) A kind of health composition and a kind of health care preparation
CN108112997B (en) A health food composition
Luo et al. Research progress of konjac dietary fibre in the prevention and treatment of diabetes
WO2006055711A1 (en) Compositions containing aloe vera isolate and a prebiotic and their therapeutic application
CN109400750B (en) Pharmaceutical composition with uric acid reducing effect
CN111543605A (en) A kind of comprehensive nutrition powder for four high or obese people
CN104707127A (en) Chewable tablet used for relieving and preventing joint diseases and preparation method thereof
CN114617267A (en) Reinforced composite bone peptide and preparation method and application thereof
CN103125808A (en) Antioxidant composite tablet for beauty and preparation method thereof
CN115153019A (en) A kind of preparation method of food for preventing and treating osteoarthritis
CN108815505B (en) Composition for improving bone density and bone joint function of middle-aged and elderly people and avoiding lumbar and leg cramps
JP2021159063A (en) Konjak functional food and method for producing the same
CN116268414A (en) Composition for improving gastrointestinal function and preventing constipation and application thereof
CN102579700A (en) Medicinal liquor for treating arthritis
CN109464651A (en) A kind of healthy food and pharmaceutical composition for improving cartilage metabolism abnormal disease
CN106728387B (en) A kind of compound medicine with promoting immune function and preparation method thereof
CN104721805A (en) Granules for alleviating and preventing joint diseases and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20221011